Standard precautions: what is meant and what is not

E.T. Curran^*
*NHS National Services Scotland, Health Protection Scotland, UK
Journal of Hospital Infection (2015) 90, 10-11
No abstract.
サマリー原文（英語）はこちら
監訳者コメント：
英国ではカルバペネム分解酵素産生菌の感染対策にからみ、標準予防策とは何かの記載について、WHO と CDC、スコットランド地方の保健当局ならびに英国のエビデンスに基づく感染予防ガイドライン（epic3 プロジェクト）との間で食い違いがあり混乱を招いていると指摘、概念の統一性と今後の進歩に期待を寄せている。

Detection of SARS-CoV-2 within the healthcare environment: a multi-centre study conducted during the first wave of the COVID-19 outbreak in England

G. Moore^*, H. Rickard, D. Stevenson, P. Aranega-Bou, J. Pitman, A. Crook, K. Davies, A. Spencer, C. Burton, L. Easterbrook, H.E. Love, S. Summers, S.R. Welch, N. Wand, K-A. Thompson, T. Pottage, K.S. Richards, J. Dunning, A. Bennett
^*Public Health England, UK

Journal of Hospital Infection (2021) 108, 189-196

Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand

Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review

Prolonged outbreak of Staphylococcus aureus surgical site infection traced to a healthcare worker with psoriasis

Efficacy of a hospital policy of selective digestive decontamination for carbapenem-resistant Enterobacterales carriers: prospective before-after study
H. Bar-Yoseph^*, C. Lulu, S. Shklar, A. Korytny, R. Even Dar, H. Daoud, K. Hussein, Y. Bar-Lavie, A. Jabareen, Y. Geffen, M. Paul, on behalf of the SHAPER Investigators
^*Rambam Health Care Campus, Israel
Journal of Hospital Infection (2020) 106, 495-499